Pharma Innovation Insights

Alex emphasizes the need for pharma companies to prioritize meaningful research over short-term gains. He warns against an overemphasis on profit-driven strategies that hinder true innovation in the industry. The discussion sheds light on the importance of balancing commercial interests with long-term scientific advancements.